11,537
Views
145
CrossRef citations to date
0
Altmetric
Review Article

Exploring versatile applications of cyclodextrins: an overview

&
Pages 729-747 | Received 25 Apr 2014, Accepted 23 Jun 2014, Published online: 22 Jul 2014

References

  • Al Omari MM, Badwan AA, Zughul MB, et al. (2007). Fexofenadine/cyclodextrin inclusion complexation: phase solubility, thermodynamic, physicochemical, and computational analysis. Drug Dev Ind Pharm 33:1205–15
  • Aleem O, Kuchekar B, Pore Y, Late S. (2008). Effect of β-cyclodextrin and hydroxypropyl β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir. J Pharm Biomed Anal 47:535–40
  • Ali N, Harikumar SL, Kaur A. (2012). Cyclodextrin: an excipient tool in drug delivery. Int J Pharm 3:44–50
  • Almagro L, Perez AL, Pedreno M. (2011). New method to enhance ajmalicine production in Catharanthus roseus cell cultures based on the use of cyclodextrins. Biotechnol Lett 33:381–5
  • Ammar H, Salama H, Ghorab M, et al. (2006). A transdermal delivery system for glipizide. Curr Drug Deliv 3:333–41
  • Ansari MT, Batty KT, Iqbal I, Sunderland VB. (2011). Improving the solubility and bioavailability of dihydroartemisinin by solid dispersions and inclusion complexes. Arch Pharmacol Res 34:757–65
  • Aranda C, Urbiola K, Mendez Ardoy A, et al. (2013). Targeted gene delivery by new folate-polycationic amphiphilic cyclodextrins-DNA nanocomplexes in vitro and in vivo. Eur J Pharm Biopharm 85:390–7
  • Arima H, Kondo T, Irie T, Uekama K. (1992). Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository. J Pharm Sci 11:1119–25
  • Arima H, Yamashita S, Mori Y, et al. (2010). In vitro and in vivo gene delivery mediated by lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes. J Control Release 146:106–17
  • Astray G, Gonzalez-Barreiro C, Mejuto J, et al. (2009). A review on the use of cyclodextrins in foods. Food Hydrocolloids 23:1631–40
  • Awasthi SS, Kumar TG, Manisha P, et al. (2011). Development of meloxicam formulations utilizing ternary complexation for solubility enhancement. Pakistan J Pharm Sci 24:533–8
  • Babu R, Pandit J. (2004). Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin. Int J Pharm 271:155–65
  • Babu RJ, Dayal P, Singh M. (2008). Effect of cyclodextrins on the complexation and nasal permeation of melatonin. Drug Deliv 15:381–8
  • Baek JS, Lim JH, Kang JS, et al. (2013). Enhanced transdermal drug delivery of zaltoprofen using a novel formulation. Int J Pharm 453:358–62
  • Baldi A. (2008). Production of anticancer drug podophyllotoxin by plant cell cultivation of Linum album [Ph.D]. Thesis, Department of Biochemical Engineering & Biotechnology. Indian Institute of Technology, Delhi
  • Balducci AG, Magosso E, Colombo G, et al. (2013). Agglomerated oral dosage forms of artemisinin/β-cyclodextrin spray-dried primary microparticles showing increased dissolution rate and bioavailability. Pharm Sci Tech 14:911–18
  • Becket G, Schep LJ, Tan MY. (1999). Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins. Int J Pharm 179:65–71
  • Belchi Navarro S, Almagro L, Lijavetzky D, et al. (2012). Enhanced extracellular production of trans-resveratrol in Vitis vinifera suspension cultured cells by using cyclodextrins and methyljasmonate. Plant Cell Rep 31:81–9
  • Borghetti GS, Pinto AP, Lula IS, et al. (2011). Daidzein/cyclodextrin/hydrophilic polymer ternary systems. Drug Dev Ind Pharm 37:886–93
  • Brewster ME, Loftsson T. (2007). Cyclodextrins as pharmaceutical solubilizers. Adv Drug Del Rev 59:645–66
  • Brewster ME, Simpkins JW, Hora MS, et al. (1989). The potential use of cyclodextrins in parenteral formulations. J Pharm Sci Technol 43:231–40
  • Buschmann HJ, Schollmeyer E. (2002). Applications of cyclodextrins in cosmetic products: a review. J Cosmet Sci 53:185–92
  • Cal K, Centkowska K. (2008). Use of cyclodextrins in topical formulations: practical aspects. Eur J Pharm Biopharm 68:467–78
  • Cappello B, Di Maio C, Iervolino M, et al. (2009). Etodolac/cyclodextrin formulations: Physicochemical characterization and in vivo pharmacological studies. Drug Dev Ind Pharm 35:877–86
  • Challa R, Ahuja A, Ali J, Khar RK. (2005). Cyclodextrins in drug delivery: an updated review. Pharm Sci Tech 6:329–57
  • Chattah AK, Mroue KH, Pfund LY, et al. (2013). Insights into novel supramolecular complexes of two solid forms of norfloxacin and β-cyclodextrin. J Pharm Sci 102:3717–24
  • Chordiya MA, Senthilkumaran K. (2012). Cyclodextrin in drug delivery: a review. Res Rev J Pharm Pharm Sci 1:19–29
  • Davis ME, Brewster ME. (2004). Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov 3:1023–35
  • De Boer T, De Zeeuw RA, De Jong GJ, Ensing K. (2000). Recent innovations in the use of charged cyclodextrins in capillary electrophoresis for chiral separations in pharmaceutical analysis. Electrophoresis 21:3220–39
  • Del Valle EM. (2004). Cyclodextrins and their uses: a review. Process Biochem 39:1033–46
  • Dos Santos C, Buera MP, Mazzobre MF. (2011). Phase solubility studies and stability of cholesterol/β-cyclodextrin inclusion complexes. J Sci Food Agric 91:2551–7
  • Durante M, Caretto S, Quarta A, et al. (2011). β-Cyclodextrins enhance artemisinin production in Artemisia annua suspension cell cultures. Appl Microbiol Biotechnol 90:1905–13
  • El Ghoul Y, Blanchemain N, Laurent T, et al. (2008). Chemical, biological and microbiological evaluation of cyclodextrin finished polyamide inguinal meshes. Acta Biomater 4:1392–400
  • El Harti J, Cherrah Y, Bouklouze A. (2012). Improvement of water solubility of josamycin by inclusion complex γ-cyclodextrin. Anal Chem 2012:1–6
  • Figueiras A, Carvalho RA, Ribeiro L, et al. (2007). Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin. Eur J Pharm Biopharm 67:531–9
  • Gao S, Wang L. (1998). Application of cyclodextrin in environmental science. Huanjing KexueJinzhan 6:80–6
  • Garnero C, Chattah AK, Longhi M. (2014). Improving furosemide polymorphs properties through supramolecular complexes of β-cyclodextrin. J Pharm Biomed Anal 95:139–45
  • Gould S, Scott RC. (2005). 2-Hydroxypropyl-b-cyclodextrin (HP-b-CD): a toxicology review. Food Chem Toxicol 43:1451–9
  • Gudmundsdottir E, Stefansson E, Bjarnadottir G, et al. (2000). Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension. Invest Ophthalmol Vis Sci 41:3552–4
  • Halim Mohamed MA, Mahmoud AA. (2011). Formulation of indomethacin eye drops via complexation with cyclodextrins. Curr Eye Res 36:208–16
  • Han C, Xu J, Wang X, et al. (2014). Enantioseparation of racemic trans-δ-viniferin using high speed counter-current chromatography based on induced circular dichroism technology. J Chromatogr A 1324:164–70
  • Ibrahim N, Abdalla W, El-Zairy E, Khalil H. (2013a). Utilization of monochloro-triazine β-cyclodextrin for enhancing printability and functionality of wool. Carbohydr Polym 92:1520–9
  • Ibrahim N, El-Zairy E, Abdalla W, Khalil H. (2013b). Combined UV-protecting and reactive printing of Cellulosic/wool blends. Carbohydr Polym 92:1386–94
  • Irie T, Uekama K. (1997). Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 86:147–62
  • Jagdale SC, Mohanty P, Chabukswar AR, Kuchekar BS. (2012). Dissolution rate enhancement, design and development of buccal drug delivery of darifenacin hydroxypropyl β-cyclodextrin inclusion complexes. J Pharm 2013:1–11
  • Jarosz PA, Fletcher E, Elserafy E, et al. (2013). The effect of α-cyclodextrin on postprandial lipid and glycemic responses to a fat-containing meal. Metabolism 62:1443–7
  • Jug M, Becirevic-Lacan M, Kwokal A, Cetina-Cizmek B. (2005). Influence of cyclodextrin complexation on piroxicam gel formulations. Acta Pharma 55:223–36
  • Jug M, Mennini N, Kover KE, Mura P. (2014). Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state. J Pharm Biomed Anal 91:81–91
  • Jung TH, Ha HJ, Ahn J, Kwak HS. (2008). Development of cholesterol-reduced mayonnaise with crosslinked beta-cyclodextrin and added phytosterol. Korean J Food Sci Anim Resources 28:211–17
  • Kane RN, Kuchekar BS. (2010). Preparation, physicochemical characterization, dissolution and formulation studies of telmisartan cyclodextrin inclusion complexes. Asian J Pharm 4:52–9
  • Karathanos VT, Mourtzinos I, Yannakopoulou K, Andrikopoulos NK. (2007). Study of the solubility, antioxidant activity and structure of inclusion complex of vanillin with β-cyclodextrin. Food Chem 101:652–8
  • Karginov VA. (2013). Cyclodextrin derivatives as anti-infectives. Curr Opin Pharmacol 13:717–25
  • Kasliwal N, Negi JS. (2011). Development, characterization and performance evaluation of oro-dispersible tablet containing aceclofenac hydroxypropyl-β-cyclodextrin binary system. J Incl Phenom Macro Chem 71:215–24
  • Kaur N, Puri R, Jain SK. (2010). Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent. Pharm Sci Tech 11:528–37
  • Kondo T, Irie T, Uekama K. (1996). Combination effects of alpha-cyclodextrin and xanthan gum on rectal absorption and metabolism of morphine from hollow-type suppositories in rabbits. Biol Pharm Bull 2:280–6
  • Kumar Das S, Rajabalaya R, David S, et al. (2013). Cyclodextrins – the molecular container. Res J Pharm Biol Chem Sci 4:1694–720
  • Kwak H, Kim S, Kim J, et al. (2004). Immobilized β-cyclodextrin as a simple and recyclable method for cholesterol removal in milk. Arch Pharmacol Res 27:873–7
  • Lai WF. (2014). Cyclodextrins in non-viral gene delivery. Biomaterials 35:401–11
  • Lakshmi PJ, Deepthi B, Rama Rao N. (2012). Rectal drug delivery: a promising route for enhancing drug absorption. Asian J Res Pharm Sci 2:143–9
  • Li W, Tan G, Zhao L, et al. (2012). Computer-aided molecular modeling study of enantioseparation of iodiconazole and structurally related triadimenol analogues by capillary electrophoresis: chiral recognition mechanism and mathematical model for predicting chiral separation. Anal Chim Acta 718:138–47
  • Loftsson T, Brewster ME, Masson M. (2004). Role of cyclodextrins in improving oral drug delivery. Am J Drug Deliv 2:261–75
  • Loftsson T, Brewster ME. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85:1017–25
  • Loftsson T, Brewster ME. (2010). Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol 62:1607–21
  • Loftsson T, Duchene D. (2007). Cyclodextrins and their pharmaceutical applications. Int J Pharm 329:1–11
  • Loftsson T, Hreinsdottir D, Masson M. (2005a). Evaluation of cyclodextrin solubilization of drugs. Int J Pharm 302:18–28
  • Loftsson T, Jarho P, Másson M, Järvinen T. (2005b). Cyclodextrins in drug delivery. Expert Opin Drug Deliv 2:335–51
  • Loftsson T, Stefansson E. (2002). Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. Acta Ophthalmol Scand 80:144–50
  • Loftsson T, Jarvinen T. (1999). Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev 36:59–79
  • Mahmoud AA, El-Feky GS, Kamel R, Awad GE. (2011). Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int J Pharm 413:229–36
  • Matsuda H, Arima H. (1999). Cyclodextrins in transdermal and rectal delivery. Adv Drug Deliv Rev 36:81–99
  • Merkus F, Verhoef J, Marttin E, et al. (1999). Cyclodextrins in nasal drug delivery. Adv Drug Deliv Rev 36:41–57
  • Miletic T, Kyriakos K, Graovac A, Ibric S. (2013). Spray-dried voriconazole–cyclodextrin complexes: solubility, dissolution rate and chemical stability. Carbohydr Polym 98:122–31
  • Miyake K, Arima H, Hirayama F, et al. (2000). Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-β-cyclodextrin. Pharm Dev Technol 5:399–407
  • Miyake K, Irie T, Arima H, et al. (1999). Characterization of itraconazole/2-hydroxypropyl-β-cyclodextrin inclusion complex in aqueous propylene glycol solution. Int J Pharm 179:237–45
  • Monteiro M, Ozzetti RA, Vergnanini AL, et al. (2011). Evaluation of octyl p-methoxycinnamate included in liposomes and cyclodextrins in anti-solar preparations: preparations, characterizations and in vitro penetration studies. Int J Nanomed 7:3045–58
  • Moriwaki C, Costa G, Ferracini C, et al. (2008). Enhancement of solubility of albendazole by complexation with β-cyclodextrin. Braz J Chem Eng 25:255–67
  • Morozumi T, Uetsuki H, Komiyama M, et al. (1991) Selective synthesis using cyclodextrins as catalyst: Part 6. Cyclodextrin modification for para selctive hydroxymethylation and hydroxyethylation of phenol. J Mol Catal 70:399–406
  • Navarro P, Nicolas TS, Gabaldon JA, et al. (2011). Effects of cyclodextrin type on vitamin C, antioxidant activity, and sensory attributes of a mandarin juice enriched with pomegranate and goji berries. J Food Sci 76:S319–24
  • Negi JS, Singh S. (2013). Spectroscopic investigation on the inclusion complex formation between amisulpride and γ-cyclodextrin. Carbohydr Polym 92:1835–43
  • Neu M, Fischer D, Kissel T. (2005). Recent advances in rational gene transfer vector design based on poly (ethylene imine) and its derivatives. J Gene Med 7:992–1009
  • Nicolescu C, Arama C, Nedelcu A, Monciu CM. (2010). Phase solubility studies of the inclusion complexes of repaglinide with β-cyclodextrin and β-cyclodextrin derivatives. Farmacia 58:620–8
  • Nitalikar MM, Sakarkar DM, Jain PV. (2012). The cyclodextrins: a review. J Curr Pharm Res 10:1–6
  • Ogawa N, Kaga M, Endo T, et al. (2012). Quetiapine free base complexed with cyclodextrins to improve solubility for parenteral use. Chem Pharm Bull 61: 809–15
  • Okimoto K, Miyake M, Ohnishi N, et al. (1998). Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE) 7m-β-CD. Pharm Res 15:1562–8
  • Ozdemir N, Erkin J. (2012). Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with β-cyclodextrin. Drug Dev Ind Pharm 38:331–40
  • Ozkan Y, Atay T, DiKmen N, et al. (2000). Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with β-cyclodextrin. Pharm Acta Helv 74:365–70
  • Palem CR, Patel S, Pokharkar VB. (2009). Solubility and stability enhancement of atorvastatin by cyclodextrin complexation. J Pharm Sci Technol 63:217–25
  • Patil JS, Kadam D, Marapur S, Kamalapur M. (2010). Inclusion complex system: a novel technique to improve the solubility and bioavailability of poorly soluble drugs: a review. Int J Pharm Sci Rev Res 2:29–34
  • Radu CD, Salariu M, Avadanei M, et al. (2013). Cotton-made cellulose support for anti-allergic pajamas. Carbohydr Polym 95:479–86
  • Rajendrakumar K, Madhusudan S, Pralhad T. (2005). Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat. Eur J Pharm Biopharm 60:39–46
  • Rao SR, Ravishankar GA. (2002). Plant cell cultures: chemical factories of secondary metabolites. Biotechnol Adv 20:101–53
  • Rasheed A, Kumar A, Sravanthi V. (2008). Cyclodextrins as drug carrier molecule: a review. Sci Pharm 76:567–98
  • Rawat S, Jain S. (2003). Rofecoxib–cyclodextrin inclusion complex for solubility enhancement. Die Pharmazie Int J Pharm Sci 58:639–41
  • Riekes MK, Tagliari MP, Granada A, et al. (2010). Enhanced solubility and dissolution rate of amiodarone by complexation with β-cyclodextrin through different methods. Mater Sci Eng C 30:1008–13
  • Rouf MA, Vural I, Bilensoy E, et al. (2011). Rapamycin-cyclodextrin complexation: improved solubility and dissolution rate. J Incl Phenom Macro Chem 70:167–75
  • Sachan NK, Pushkar S, Solanki S, Bhatere D. (2010). Enhancement of solubility of acyclovir by solid dispersion and inclusion complexation methods. World Appl Sci J 11:857–64
  • Schneiderman E, Stalcup AM. (2000). Cyclodextrins: a versatile tool in separation science. J Chromatogr B Biomed Sci Appl 745:83–102
  • Shokri J, Hasanzadeh D, Ghanbarzadeh S, et al. (2013). The effect of beta-cyclodextrin on percutaneous absorption of commonly used Eusolex® sunscreens. Drug Res 63:591–6
  • Singer Y, Shity H, Bar R. (1991). Microbial transformations in a cyclodextrin medium. Part 2. Reduction of androstenedione to testosterone by Saccharomyces cerevisiae. Appl Microbial Biotechnol 35:731–7
  • Singh M, Sharma R, Banerjee U. (2002). Biotechnological applications of cyclodextrins. Biotechnol Adv 20:341–59
  • Singh R, Bharti N, Madan J, Hiremath S. (2010). Characterization of cyclodextrin inclusion complexes – a review. J Pharm Sci Technol 2:171–83
  • Sridevi S, Diwan P. (2002). Effect of pH and complexation on transdermal permeation of gliquidone. Die Pharmazie 57:632–4
  • Szejtli J. (1989). Downstream processing using cyclodextrins. Trends Biotechnol 7:170–4
  • Szejtli J. (1998). Introduction and general overview of cyclodextrin chemistry. Chem Rev 98:1743–54
  • Szejtli J. (2004). Past, present and future of cyclodextrin research. Pure Appl Chem 76:1825–45
  • Szente L, Szejtli J. (1999). Highly soluble cyclodextrin derivatives: chemistry, properties and trends in development. Adv Drug Deliv Rev 36:17–28
  • Szente L, Szejtli J. (2004). Cyclodextrins as food ingredients. Trends Food Sci Technol 15:137–42
  • Tamamoto LC, Schmidt SJ, Lee SY. (2010). Sensory properties of ginseng solutions modified by masking agents. J Food Sci 75:S341–7
  • Tewes F, Brillault J, Couet W, Olivier JC. (2008). Formulation of rifampicin-cyclodextrin complexes for lung nebulization. J Control Release 129:93–9
  • Tiwari G, Tiwari R, Rai AK. (2010). Cyclodextrins in delivery systems: applications. J Pharm Bio Allied Sci 2:72–9
  • Voncina B. (2011). Application of cyclodextrins in textile dyeing. Textile dyeing. Rijeka: In Tech, 373–92
  • Wang S, Li D, Ito Y, et al. (2004). An ocular drug delivery system containing zinc diethyl dithiocarbamate and HPβCD inclusion complex-corneal permeability, anti-cataract effects and mechanism studies. J Pharm Pharmacol 56:1251–7
  • Wang Y, Qiao X, Li W, et al. (2009). Study on the complexation of isoquercitrin with β-cyclodextrin and its derivatives by spectroscopy. Anal Chimi Acta 650:124–30
  • Weisheimer V, Miron D, Silva C, et al. (2010). Microparticles containing lemongrass volatile oil: Preparation, characterization and thermal stability. Die Pharmazie Int J Pharm Sci 65:885–90
  • Wempe MF, Wacher VJ, Ruble KM, et al. (2008). Pharmacokinetics of raloxifene in male Wistar–Hannover rats: influence of complexation with hydroxybutenyl-beta-cyclodextrin. Int J Pharm 346:25–37
  • Wen J, Liu B, Yuan E, et al. (2010). Preparation and physicochemical properties of the complex of naringenin with hydroxypropyl-β-cyclodextrin. Molecules 15:4401–7
  • Woerdenbag HJ, Pras N, Frijlink HW, et al. (1990). Cyclodextrin-facilitated bioconversion of 17 beta-estradiol by a phenoloxidase from Mucuna pruriens cell cultures. Phytochemistry 29:1551–4
  • Wu J, Shen Q, Fang L. (2013). Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel. Drug Dev Ind Pharm 39:1010–19
  • Wu Y, Jiang F, Chen L, et al. (2011). Determination of phenylenediamine isomers in hair dyes by coal cinders micro-column extraction and MEKC. Anal Bioanal Chem 400:2141–7
  • Xing J, Chen L, Song J, et al. (2012). Separation and determination of resibufogenin and cinobufagin in Chansu using reversed-phase liquid chromatography with γ-cyclodextrin as mobile-phase modifier. J Sep Sci 35:1884–92
  • Yang B, Lin J, Chen Y, Liu Y. (2009). Artemether/hydroxypropyl-β-cyclodextrin host–guest system: characterization, phase-solubility and inclusion mode. Bioorg Med Chem 17:6311–17
  • Young O, Gupta R, Sadooghy-Saraby S. (2012). Effects of cyclodextrins on the flavor of goat milk and its yogurt. J Food Sci 77:S122–7
  • Zhang J, Shen X, Chen Q. (2011). Separation processes in the presence of cyclodextrins using molecular imprinting technology and ionic liquid cooperating approach. Curr Org Chem 15:74–85
  • Zhang MQ, Rees DC. (1999). A review of recent applications of cyclodextrins for drug discovery. Expert Opin Ther Pat 9:1697–717
  • Zhao MX, Li JM, Du L, et al. (2011). Targeted cellular uptake and siRNA silencing by quantum-dot nanoparticles coated with β-cyclodextrin coupled to amino acids. Eur J Chem 17:5171–9
  • Zhu Q, Guo T, Xia D, et al. (2013). Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration. J Pharm Pharmacol 65:1107–17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.